Why the study?
With rising AF prevalence and increasing demand for ablation, centres need to maximize capacity by adding resources or optimizing process management.
Does process optimization using Lean Six Sigma improve procedural efficiency and safety in patients undergoing cryoballoon pulmonary vein isolation for atrial fibrillation?
Does process optimization using Lean Six Sigma improve procedural efficiency and safety in patients undergoing cryoballoon pulmonary vein isolation for atrial fibrillation?
Applying Lean Six Sigma process optimization to atrial fibrillation ablation significantly improves procedural efficiency, reducing procedure times and radiation exposure without compromising patient safety.
Answers are grounded in this paper and cite their sources.
Lean Six Sigma optimization may boost single-center ablation efficiency without safety loss; leaves open reproducibility and capacity impact across centers.
AIMS: In the light of an increasing prevalence of atrial fibrillation (AF) and growing evidence for the superiority of early invasive rhythm control, the demand for ablation therapy is rising. Accordingly, ablation centres will have to maximize their capacity by either adding electrophysiology laboratory resources or optimizing process management. In order to optimize process management, we applied "Lean Six Sigma" method to a single ablation center. We compared procedural parameters, acute efficacy and safety of cryoballoon pulmonary vein isolation (cryoPVI) before and after modifications. METHODS AND RESULTS: Patients (n = 713) undergoing cryoPVI (108 before and 605 after process optimization) were analysed. Within 3 years of process optimization, electrophysiology laboratory occupancy time (150.7 ± 44.4 vs. 94 ± 22.1 min, P < 0.001), procedure time (84.5 ± 21-47.4 ± 12 min, P < 0.001), left-atrial dwell time (53.9 ± 18.4-31.9 ± 9.9 min, P < 0.001), and fluoroscopy time (15.8 ± 5.1 vs. 6.2 ± 2.8 min, P < 0.001) decreased. Contrast dye use (116 ± 35 vs. 27 ± 15 mL, P < 0.001) and radiation dose (893 ± 1078 vs. 253 ± 249 cGy cm2, P < 0.001) were reduced by ∼77 and ∼72%, respectively. There was no difference in safety endpoint occurrence (3.7 vs. 1.5%, P = 0.11). CONCLUSION: The process optimization of cryoPVI for AF therapy using the 'Lean Six Sigma' method significantly increases efficiency without compromising patient safety.
No takes yet. Share an insight, caveat, or question.
Boehmer et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: